MAURICE JOHNSON: Open Payments
NPI 1689751497 · CORTLANDT MANOR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 15 payments from 8 companies in 2025. Trend: 2023 $18 · 2024 $387 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $75 |
| Lilly USA, LLC | 2 | $51 |
| PFIZER INC. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: MOUNJARO, PREVNAR 20, TRELEGY ELLIPTA, BREZTRI, REXULTI, JARDIANCE, Wegovy, Veozah.
Industry payments across NY — which companies pay providers there.
